Dose-Response Relationship, Immunologic
"Dose-Response Relationship, Immunologic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell.
Descriptor ID |
D004306
|
MeSH Number(s) |
G12.300
|
Concept/Terms |
Dose-Response Relationship, Immunologic- Dose-Response Relationship, Immunologic
- Dose Response Relationship, Immunologic
- Immunologic Dose-Response Relationship
- Dose-Response Relationships, Immunologic
- Immunologic Dose Response Relationship
- Immunologic Dose-Response Relationships
- Relationships, Immunologic Dose-Response
- Relationship, Immunologic Dose-Response
- Relationship, Immunologic Dose Response
|
Below are MeSH descriptors whose meaning is more general than "Dose-Response Relationship, Immunologic".
Below are MeSH descriptors whose meaning is more specific than "Dose-Response Relationship, Immunologic".
This graph shows the total number of publications written about "Dose-Response Relationship, Immunologic" by people in this website by year, and whether "Dose-Response Relationship, Immunologic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1983 | 0 | 2 | 2 | 1984 | 0 | 2 | 2 | 1986 | 0 | 1 | 1 | 1987 | 0 | 1 | 1 | 1988 | 0 | 1 | 1 | 1989 | 0 | 3 | 3 | 1990 | 0 | 1 | 1 | 1991 | 0 | 1 | 1 | 1992 | 0 | 5 | 5 | 1995 | 0 | 1 | 1 | 1996 | 0 | 1 | 1 | 1999 | 0 | 1 | 1 | 2000 | 0 | 2 | 2 | 2001 | 0 | 1 | 1 | 2003 | 0 | 1 | 1 | 2004 | 0 | 2 | 2 | 2005 | 0 | 2 | 2 | 2007 | 0 | 1 | 1 | 2008 | 0 | 2 | 2 | 2011 | 0 | 2 | 2 | 2012 | 0 | 3 | 3 | 2014 | 0 | 1 | 1 | 2017 | 0 | 1 | 1 | 2018 | 0 | 1 | 1 | 2022 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Dose-Response Relationship, Immunologic" by people in Profiles.
-
Chen X, Schneewind O, Missiakas D. Engineered human antibodies for the opsonization and killing of Staphylococcus aureus. Proc Natl Acad Sci U S A. 2022 01 25; 119(4).
-
Christe KL, Salyards GW, Houghton SD, Ardeshir A, Yee JL. Modified Dose Efficacy Trial of a Canine Distemper-Measles Vaccine for Use in Rhesus Macaques (Macaca mulatta). J Am Assoc Lab Anim Sci. 2019 05 01; 58(3):397-405.
-
AR101 Oral Immunotherapy for Peanut Allergy. N Engl J Med. 2018 Nov 22; 379(21):1991-2001.
-
Moulin M, Alguacil J, Gu S, Mehtougui A, Adams EJ, Peyrottes S, Champagne E. V?9Vd2 T cell activation by strongly agonistic nucleotidic phosphoantigens. Cell Mol Life Sci. 2017 12; 74(23):4353-4367.
-
Hazama S, Nakamura Y, Takenouchi H, Suzuki N, Tsunedomi R, Inoue Y, Tokuhisa Y, Iizuka N, Yoshino S, Takeda K, Shinozaki H, Kamiya A, Furukawa H, Oka M. A phase I study of combination vaccine treatment of five therapeutic epitope-peptides for metastatic colorectal cancer; safety, immunological response, and clinical outcome. J Transl Med. 2014 Mar 10; 12:63.
-
Harper DM, Verdenius I, Ratnaraj F, Arey AM, Rosemergey B, Malnar GJ, Wall J. Quantifying clinical HPV4 dose inefficiencies in a safety net population. PLoS One. 2013; 8(11):e77961.
-
Hartung HP, Kieseier B, Goodin DS, Arnason BG, Comi G, Cook S, Filippi M, Jeffery DR, Kappos L, Bogumil T, Stemper B, Sandbrink R, Nakada Y, Nakajima H, Schwenke S, Lehr S, Heubach J, Pohl C, Reischl J. Variability in detection and quantification of interferon ß-1b-induced neutralizing antibodies. J Neuroinflammation. 2012 Jun 15; 9:129.
-
Schley D, Tanaka RJ, Leungchavaphongse K, Shahrezaei V, Ward J, Grant C, Charleston B, Rhodes CJ. Modelling the influence of foot-and-mouth disease vaccine antigen stability and dose on the bovine immune response. PLoS One. 2012; 7(2):e30435.
-
Ji Y, Feng L, Liu P, Shpall EJ, Kebriaei P, Champlin R, Berry D, Cooper LJ. Bayesian continual reassessment method for dose-finding trials infusing T cells with limited sample size. J Biopharm Stat. 2012; 22(6):1206-19.
-
Richman DP, Nishi K, Morell SW, Chang JM, Ferns MJ, Wollmann RL, Maselli RA, Schnier J, Agius MA. Acute severe animal model of anti-muscle-specific kinase myasthenia: combined postsynaptic and presynaptic changes. Arch Neurol. 2012 Apr; 69(4):453-60.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|